Barbara Jean Bormann

Title: Barbara Jean Bormann: Innovator in Inflammatory Disease Treatment

Introduction

Barbara Jean Bormann is a notable inventor based in Old Lyme, Connecticut. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory diseases. With a total of 2 patents, her work has garnered attention for its innovative approaches and potential applications.

Latest Patents

Bormann's latest patents include groundbreaking compounds such as phenylpyrrolidines, phenylimidazolidines, 3-phenyl-1,3-oxizolidines, and 3-phenyl-1,3-thiazolidines. These compounds are designed for the treatment and prevention of inflammatory and immune cell-mediated diseases through the administration of novel small molecules. One of her notable inventions involves immortalized brain endothelial cells, which maintain a normal cell phenotype and form monolayers that are substantially impermeable to low molecular weight molecules. These cells are particularly useful for in vitro studies involving the blood-brain barrier.

Career Highlights

Barbara Jean Bormann is currently employed at Boehringer Ingelheim Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work has been instrumental in creating innovative solutions for complex medical challenges.

Collaborations

Throughout her career, Bormann has collaborated with esteemed colleagues such as Jiang-Ping Wu and Leah Lynn Frye. These partnerships have contributed to the success of her research and the development of her patented inventions.

Conclusion

Barbara Jean Bormann is a pioneering inventor whose work in the pharmaceutical industry has the potential to transform the treatment of inflammatory diseases. Her innovative patents and collaborations highlight her commitment to advancing medical science.